openPR Logo
Press release

Oncology Information System Market New Innovations, Challenges, Opportunities, Strategies and Forecast By 2031 | Cerner Corporation, CureMD Corporation, Elekta AB, F. Hoffmann LA Roche AG

11-24-2022 06:41 AM CET | Health & Medicine

Press release from: Global Insight Services

Oncology Information System Market

Oncology Information System Market

New York, According to a new market research report published by Global Insight Services Oncology Information System Market is expected to reach US$ XX bn by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

An oncology information system (OIS) is a type of electronic medical record (EMR) system specifically designed for oncology practices. An OIS typically includes features and functionality such as cancer staging, treatment planning, and clinical decision support tools that are not found in a traditional EMR system.

View Detailed Report Description : https://www.globalinsightservices.com/reports/oncology-information-system-market

Key Trends

The key trends in Oncology Information System technology are:

1. The use of big data and analytics to improve patient care and outcomes.

2. The use of cloud-based solutions to improve access to care.

3. The use of mobile apps to improve patient engagement.

4. The use of artificial intelligence and machine learning to improve decision-making.

Request Sample Report : https://www.globalinsightservices.com/request-sample/GIS20816

Key Drivers

The key drivers of the Oncology Information System market include the rising prevalence of cancer, the increasing number of cancer patients, the increasing number of hospitals and clinics, the rising demand for efficient and effective cancer treatment, and the increasing government funding for cancer research.

The rising prevalence of cancer is one of the major drivers of the Oncology Information System market. Cancer is a leading cause of death worldwide, and the number of cancer cases is increasing rapidly. According to the World Health Organization, the number of new cancer cases is expected to increase by about 70% over the next two decades. This increase is mainly due to the aging population and the changing lifestyles. The number of cancer patients is also increasing due to the increasing survival rates.

The increasing number of hospitals and clinics is another key driver of the Oncology Information System market. Hospitals and clinics are the main users of oncology information systems. The rising number of hospitals and clinics is due to the increasing number of cancer patients and the rising demand for efficient and effective cancer treatment.

The rising demand for efficient and effective cancer treatment is another driver of the Oncology Information System market. Cancer treatment is becoming more complex and expensive, and the need for efficient and effective cancer treatment is increasing. Oncology information systems help clinicians to manage the increasing complexity of cancer treatment and to improve the outcomes of treatment.

Purchase your copy now : https://www.globalinsightservices.com/checkout/single_user/GIS20816

Market Segmentation

The OIS market is segmented into product & services, application, end user, and region. Based on product & service, it is bifurcated into software and services. By application, it is fragmented into radiation, medical, and surgical oncology. On the basis of end user, it is classified into hospitals & oncology clinics and research centres. By region the market is segmented into North America, Europe, Asia-Pacific and rest of the world.

Key Players

The key players in the market are Accuray Incorporated, BMSI Partners Inc., Cerner Corporation, CureMD Corporation, Elekta AB, F. Hoffmann LA Roche AG, Siemens AG, Koninklijke Philips N.V, McKesson Corporation, and Nasdaq Inc.

Request For Customization : https://www.globalinsightservices.com/request-customization/GIS20816

Reasons to buy Oncology Information System Market Report:

• Develop comprehensive understanding of market landscape - industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncology Information System Market New Innovations, Challenges, Opportunities, Strategies and Forecast By 2031 | Cerner Corporation, CureMD Corporation, Elekta AB, F. Hoffmann LA Roche AG here

News-ID: 2819279 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for Oncology

Precision Oncology Market Top Companies Study - Laboratory Corporation of Americ …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies)- Market Outlook And Industry Analysis 2031" The global Precision Oncology market is estimated to reach over USD
Veterinary Oncology Market Report 2024 - Veterinary Oncology Market Size, Share …
"The Business Research Company recently released a comprehensive report on the Global Veterinary Oncology Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The veterinary oncology market size
Hepatocellular Carcinoma Pipeline 2024 | Can-Fite BioPharma, Sinocelltech, AVEO …
DelveInsight, "Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatocellular Carcinoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Hepatocellular Carcinoma Pipeline
Oncology Clinical Trials Market: Collaboration and Innovation in Oncology Resear …
Allied Market Research analysts have recently conducted a comprehensive research study titled "Oncology Clinical Trials Market: Global Outlook and Forecast 2023-2030." The report provides detailed information and analysis on key players in the market, including PAREXEL International, PRA Health Sciences, Syneos Health, Medpace, Novotech, Pivotal, Novartis, Merck, Bristol Myers Squibb company, and F. Hoffmann-La Roche. The study offers an in-depth analysis that encompasses clear market definitions, classifications, manufacturing processes, cost
Hemato Oncology Testing Market Global Hemato Oncology Testing Market, Hemato Onc …
Global Hemato Oncology Testing Market Research report is an in-depth study of the market Analysis. Along with the most recent patterns and figures that uncovers a wide examination of the market offer. This report provides exhaustive coverage on geographical segmentation, latest demand scope, growth rate analysis with industry revenue and CAGR status. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study
Oncology Market Size to Hit $447.3 Billion by 2028 | Oncology Industry Forecast …
Market Overview: According to our experience research team, Oncology Market was valued at USD 283.5 Billion in 2021, and the global Oncology industry is projected to reach a value of USD 447.3 Billion by 2028, at a CAGR of 7.9% during the forecast period 2022-2028 Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy & Power, Agriculture,